Trials / Completed
CompletedNCT04293289
Boron Neutron Capture Therapy Using CICS-1 and SPM-011 for Malignant Melanoma and Angiosarcoma
Phase 1 Clinical Trial of Boron Neutron Capture Therapy (BNCT) Using CICS-1 and SPM-011 for Malignant Melanoma and Angiosarcoma
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Cancer Intelligence Care Systems, Inc. · Industry
- Sex
- All
- Age
- 20 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
Among skin malignancies, patients with malignant melanoma or angiosarcoma are treated with BNCT using CICS-1 and SPM-011 (borofalan (10B)). Through this trial, safety and appropriate treatment dose will be determined.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | CICS-1 (investigational device),SPM-011(investigational drug) | Intravenous administration of SPM-011 and neutron irradiation with CICS-1. |
Timeline
- Start date
- 2019-11-19
- Primary completion
- 2022-12-31
- Completion
- 2022-12-31
- First posted
- 2020-03-03
- Last updated
- 2023-02-08
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT04293289. Inclusion in this directory is not an endorsement.